RISK FACTOR, CARDIOVASCULAR
Clinical trials for RISK FACTOR, CARDIOVASCULAR explained in plain language.
Never miss a new study
Get alerted when new RISK FACTOR, CARDIOVASCULAR trials appear
Sign up with your email to follow new studies for RISK FACTOR, CARDIOVASCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Shielding the heart from Chemo's hidden danger
Disease control CompletedThis study tested if giving a heart medication called carvedilol to breast cancer patients at higher risk of heart damage could protect their hearts during chemotherapy. It involved 68 women receiving specific cancer drugs (doxorubicin and/or trastuzumab). The goal was to see if …
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Tracking the Heart's response to powerful cancer treatment
Knowledge-focused CompletedThis study aims to understand how CAR-T cell therapy, a treatment for certain blood cancers, affects heart function. Researchers followed 44 adults before and after receiving the therapy, checking their hearts with ultrasound scans and blood tests over six months. The goal is to …
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC